Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan T Chlebowski

Showing results (321-330 of 366) with videos related to

Pageof 37
Sort By:
Lancet (London, England)|September 22, 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialRowan T Chlebowski, Ann G Schwartz, Heather Wakelee, et al.
Menopause (New York, N.Y.)|June 9, 2026
Low-fat dietary pattern and dementia mortality: a secondary analysis of the Women's Health Initiative dietary modification randomized clinical trial with long-term follow-upRowan T Chlebowski, Stephen Rapp, Aaron K Aragaki, et al.
Annals of Internal Medicine|July 7, 2025
Development and Validation of Body Mass Index-Specific Waist Circumference Thresholds in Postmenopausal Women : A Prospective Cohort StudyAaron K Aragaki, JoAnn E Manson, Erin S LeBlanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized TrialRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Journal of the National Cancer Institute|June 12, 2019
Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health InitiativeKathy Pan, Rebecca A Nelson, Jean Wactawski-Wende, et al.
Menopause (New York, N.Y.)|August 1, 2023
Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trialsRita Peila, Xiaonan Xue, Michael J LaMonte, et al.
BMC Women'S Health|February 5, 2022
Cardiometabolic risk factors, physical activity, and postmenopausal breast cancer mortality: results from the Women's Health InitiativeChristina M Dieli-Conwright, Rebecca A Nelson, Michael S Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002Eric P Winer, Clifford Hudis, Harold J Burstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2014
American Society of Clinical Oncology position statement on obesity and cancerJennifer A Ligibel, Catherine M Alfano, Kerry S Courneya, et al.
Cancer|July 6, 2021
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health InitiativeAllison W Kurian, Elisha Hughes, Timothy Simmons, et al.
Pageof 37

Showing results (321-330 of 366) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|September 22, 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialRowan T Chlebowski, Ann G Schwartz, Heather Wakelee, et al.
Menopause (New York, N.Y.)|June 9, 2026
Low-fat dietary pattern and dementia mortality: a secondary analysis of the Women's Health Initiative dietary modification randomized clinical trial with long-term follow-upRowan T Chlebowski, Stephen Rapp, Aaron K Aragaki, et al.
Annals of Internal Medicine|July 7, 2025
Development and Validation of Body Mass Index-Specific Waist Circumference Thresholds in Postmenopausal Women : A Prospective Cohort StudyAaron K Aragaki, JoAnn E Manson, Erin S LeBlanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized TrialRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Journal of the National Cancer Institute|June 12, 2019
Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health InitiativeKathy Pan, Rebecca A Nelson, Jean Wactawski-Wende, et al.
Menopause (New York, N.Y.)|August 1, 2023
Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trialsRita Peila, Xiaonan Xue, Michael J LaMonte, et al.
BMC Women'S Health|February 5, 2022
Cardiometabolic risk factors, physical activity, and postmenopausal breast cancer mortality: results from the Women's Health InitiativeChristina M Dieli-Conwright, Rebecca A Nelson, Michael S Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002Eric P Winer, Clifford Hudis, Harold J Burstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2014
American Society of Clinical Oncology position statement on obesity and cancerJennifer A Ligibel, Catherine M Alfano, Kerry S Courneya, et al.
Cancer|July 6, 2021
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health InitiativeAllison W Kurian, Elisha Hughes, Timothy Simmons, et al.
Pageof 37